ASX:MAP

Microba Life Sciences (MAP) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free MAP Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Microba Life Sciences alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; testing and data analysis services for personal and research testing; and data-driven therapeutics platform that develops novel monoclonal microbial cell therapies for inflammatory bowel disease, cancer immunotherapy, and autoimmune diseases, as well as Databank for health and biome data. The company was incorporated in 2017 and is based in Brisbane, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MAP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive MAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microba Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: ASX:MAP
CUSIP: N/A
CIK: N/A
Web: microba.com
Phone: 61 13 0097 4621
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,490,000.00
Net Margins: -282.64%
Pretax Margin: N/A
Return on Equity: -39.09%
Return on Assets: -27.33%

Debt

Debt-to-Equity Ratio: 2.80
Current Ratio: 3.27
Quick Ratio: 6.50

Sales & Book Value

Annual Sales: $6.54 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.11 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 447,850,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Dr. Luke Reid
Chief Executive Officer
Prof. Gene Tyson
Co-Founder & Non-Executive Director
Mr. James Heath
CFO & Joint Company Secretary
Prof. Philip Hugenholtz
Co-Founder & Chair of Scientific Advisory Board
Mr. Yao Liu
Chief Technology Officer
Prof. Lutz Krause
Chief Scientific Officer
Mr. Drew Webb
Chief Marketing Officer
Prof. Trent Munro
Senior Vice President of Therapeutics
Dr. Nicola Angel
Head of Laboratory Operations
Mr. Bernie Woodcroft
Senior Vice President of Platform Solutions

Key Competitors

View All Competitors

Insiders

This page (ASX:MAP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Microba Life Sciences (MAP) Stock Price, News & Analysis

About Microba Life Sciences

MAP Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info